JLB & Associates’s Maximus MMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,210
Closed -$462K 75
2026
Q1
$462K Buy
7,210
+1,003
+16% +$81.4K 0.07% 67
2025
Q4
$536K Sell
6,207
-242
-4% -$20.7K 0.07% 65
2025
Q3
$589K Sell
6,449
-160
-2% -$13K 0.08% 64
2025
Q2
$464K Sell
6,609
-534
-7% -$37.5K 0.06% 69
2025
Q1
$487K Sell
7,143
-235
-3% -$16.7K 0.07% 70
2024
Q4
$551K Sell
7,378
-588
-7% -$48K 0.07% 71
2024
Q3
$742K Hold
7,966
0.1% 69
2024
Q2
$683K Sell
7,966
-12
-0.2% -$1.01K 0.09% 73
2024
Q1
$669K Buy
7,978
+1,808
+29% +$149K 0.09% 71
2023
Q4
$517K Hold
6,170
0.07% 71
2023
Q3
$461K Buy
6,170
+601
+11% +$48.9K 0.07% 69
2023
Q2
$471K Sell
5,569
-167
-3% -$13.7K 0.07% 72
2023
Q1
$451K Hold
5,736
0.07% 70
2022
Q4
$420K Sell
5,736
-47
-0.8% -$3.03K 0.07% 69
2022
Q3
$334K Buy
5,783
+165
+3% +$10.3K 0.06% 69
2022
Q2
$351K Sell
5,618
-351
-6% -$23.7K 0.06% 69
2022
Q1
$447K Buy
5,969
+430
+8% +$32.9K 0.07% 70
2021
Q4
$441K Buy
5,539
+406
+8% +$33.2K 0.06% 72
2021
Q3
$427K Buy
5,133
+1,147
+29% +$98.3K 0.07% 70
2021
Q2
$350K Buy
3,986
+1,332
+50% +$122K 0.05% 70
2021
Q1
$236K Buy
+2,654
New +$217K 0.04% 71

Other funds holding MMS

JLB & Associates's MMS Position: Q2 2026 in Review

JLB & Associates sold out of Maximus (MMS) in Q2 2026, closing a stake of 7,210 shares — an estimated $462K sold.

JLB & Associates first reported a position in MMS in Q1 2021 and held it in 21 quarters. The position peaked at $742K in Q3 2024. 349 funds tracked by Wall St. Rank hold MMS as of Q2 2026.

  • JLB & Associates reported no remaining Maximus position as of Q2 2026 after selling out during the quarter.
  • JLB & Associates sold 7,210 Maximus shares in Q2 2026, an estimated $462K.
  • JLB & Associates first reported a position in Maximus in Q1 2021 and held it in 21 quarters.
  • JLB & Associates's Maximus position peaked at $742K in Q3 2024.
  • 349 funds tracked by Wall St. Rank held Maximus as of Q2 2026.

Based on JLB & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.